All the news Showing 10 of 178 articles from: Finance, funding & health economicsGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Why are hepatitis C patients treated differently by NHS England? Pharmaceutical Journal / 15 August 2016 Fighting the War on HCV Within the Veterans Health Administration System HCV Next / 21 June 2016 Large global range of prices for hepatitis C medicines raises concerns about affordability Manual Items / 01 June 2016 Burden of pricey hepatitis C drugs heaviest in eastern Europe Reuters / 01 June 2016 Antiviral prophylaxis cost-effective to prevent perinatal HBV transmission Healio / 11 May 2016 Covering Costly HCV Tx: Who Makes that Call? Manual Items / 11 May 2016 It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments American Journal of Managed Care / 10 May 2016 A Way Out of the Dismal Arithmetic of Hepatitis C Treatment American Journal of Managed Care / 10 May 2016 Study: Cheaper to cure hepatitis C sooner than later UPI.com / 10 May 2016 Sky-high price of hepatitis C drug produces profits for lawmakers Center for Responsive Politics / 05 May 2016 ← Prev1...34567...18Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Email bulletin archive